Capsugel expands capsule line with Encap purchase; TheraCoat introduces hydrogel delivery for bladder diseases;

@MichaelGFierce: Yale researchers improve lupus drug with nanogel delivery. More | Follow @MichaelGFierce

> Capsugel bought Scottish company Encap Drug Delivery in an effort to bolster its formulation and manufacturing business, adding liquid and semi-solid capsules on top of its line of hard-capsule drugs. Article

> TheraCoat developed a hydrogel-based drug delivery system that enables more controlled treatment of bladder diseases and is seeking commercial partners. Release

> Last month, President Barack Obama awarded MIT professor and drug delivery innovator Robert Langer with the National Medal of Technology and Innovation--in-Pharma Technologist caught up with Langer for an interview.

> The FDA is scheduled to review Titan Pharmaceuticals' Probuphine, a subdermal implant for the treatment of opioid dependence, near the end of March. Release

> Researchers at the University of Cincinnati have developed circulating microbubbles that encapsulate and shield drugs in the blood stream during the treatment of cardiovascular diseases. Abstract

> Ranbaxy Pharmaceuticals entered an agreement with Alembic Pharmaceuticals to exclusively market Alembic's extended release depression drug desvenlafaxine in the U.S. Item

Suggested Articles

Takeda forged a feasibility pact to see whether it could pair a plasma-based therapy with Elektrofi's microparticle delivery tech.

RNA nanoparticles can squeeze into tumors and exit swiftly through the kidney, perfect for targeted delivery of cancer drugs, an OSU team says.

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.